Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation.

Journal of translational medicine·2022

Same author

Resequencing of four novel alleles with nanopore technology.

HLA·2018

Same author

Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival.

International journal of immunogenetics·2018

Same author

International Forum on GMP-grade human platelet lysate for cell propagation: summary.

Vox sanguinis·2017

Same author

International Forum on GMP-grade human platelet lysate for cell propagation.

Vox sanguinis·2017

Same author

A hybrid, low-cost tissue-like epidural needle insertion simulator.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2017

Search research articles

Related Experiment Video

Updated: May 25, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

HLA-E polymorphisms in hematopoietic stem cell transplantation.

D Fürst¹, J Bindja, R Arnold

¹Department of Transplantation Immunology, Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden-Wuerttemberg - Hessia, Ulm, Germany. d.fuerst@blutpspende.de

Tissue Antigens

|January 20, 2012

Summary

Human leukocyte antigen (HLA)-E polymorphisms did not impact hematopoietic stem cell transplantation (HSCT) outcomes in our study. Our findings suggest HLA-E genotype unlikely affects patient survival or complications post-HSCT.

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Related Experiment Videos

Last Updated: May 25, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Area of Science:

Immunogenetics
Transplantation immunology
Cellular immunology

Background:

Human leukocyte antigen (HLA)-E is a key immune regulator, interacting with natural killer cells and gamma-delta T-cells.
Previous studies suggested HLA-E allele expression influences hematopoietic stem cell transplantation (HSCT) outcomes.
The role of HLA-E in HSCT requires further investigation to clarify its clinical significance.

Purpose of the Study:

To investigate the association between HLA-E polymorphisms and clinical outcomes in HSCT.
To assess the impact of HLA-E genotypes on overall survival, disease-free survival, relapse, transplant-related mortality, and acute graft-versus-host disease.
To validate or refute previous findings on HLA-E's influence in HSCT.

Main Methods:

HLA-E genotyping was performed on 116 HSCT patients and their HLA-matched unrelated donors.
Statistical analyses, including univariate and multivariate models, were used to evaluate endpoints.
Key outcomes assessed included overall survival (OS), disease-free survival (DFS), relapse incidence, TRM, and aGvHD.

Main Results:

No statistically significant association was found between HLA-E polymorphisms and any of the investigated HSCT endpoints.
Neither univariate nor multivariate analyses revealed a correlation between HLA-E genotypes and patient survival or disease recurrence.
The study failed to confirm the previously reported influence of HLA-E on HSCT outcomes within this cohort.

Conclusions:

HLA-E polymorphisms do not appear to significantly affect the outcomes of hematopoietic stem cell transplantation in the studied patient cohort.
The findings contradict some prior research, suggesting HLA-E's role in HSCT may be less influential than previously thought.
Further research in diverse populations may be warranted, but current evidence suggests HLA-E is unlikely to be a major determinant of HSCT success.